Quarter Period Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7714364

Concept 2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
Quarter period statement of income
Statement of income
Net sales
72,584,000,000 JPY
72,584,000,000 JPY
JPY
1,764,000,000 JPY
70,820,000,000 JPY
76,891,000,000 JPY
JPY
75,099,000,000 JPY
76,891,000,000 JPY
1,792,000,000 JPY
Cost of sales
30,775,000,000 JPY
32,484,000,000 JPY
Gross profit (loss)
41,809,000,000 JPY
44,406,000,000 JPY
Selling, general and administrative expenses
21,905,000,000 JPY
20,700,000,000 JPY
Selling, general and administrative expenses
Salaries
5,156,000,000 JPY
5,379,000,000 JPY
Operating profit (loss)
19,903,000,000 JPY
19,903,000,000 JPY
JPY
1,103,000,000 JPY
18,799,000,000 JPY
23,706,000,000 JPY
JPY
22,469,000,000 JPY
23,706,000,000 JPY
1,237,000,000 JPY
Non-operating income
Interest income
4,000,000 JPY
3,000,000 JPY
Dividend income
343,000,000 JPY
301,000,000 JPY
Non-operating income
412,000,000 JPY
378,000,000 JPY
Non-operating expenses
Interest expenses
13,000,000 JPY
12,000,000 JPY
Non-operating expenses
61,000,000 JPY
22,000,000 JPY
Ordinary profit (loss)
20,254,000,000 JPY
24,062,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
JPY
Extraordinary losses
Extraordinary losses
32,000,000 JPY
51,000,000 JPY
Profit (loss) before income taxes
20,222,000,000 JPY
24,011,000,000 JPY
Income taxes
5,975,000,000 JPY
7,152,000,000 JPY
Profit (loss)
14,247,000,000 JPY
16,859,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.